Ian F. Smith

Chief Financial Officer, Vertex Pharmaceuticals.

Companies

Odyssey Therapeutics, Inc.Board member May 7, 2026 to now¹
Stoke Therapeutics, Inc.Chief executive officer Mar 20, 2025 to now²
Stoke Therapeutics, Inc.Board member Sep 20, 2023 to now³
Foghorn Therapeutics Inc.Board member Apr 29, 2021 to now⁴
Solid Biosciences Inc.Board member Apr 16, 2020 to now⁵
Vertex PharmaceuticalsChief operating officer Feb 7, 2017 to Jul 3, 2018⁶
Acorda TherapeuticsBoard member Feb 5, 2007 to Jun 29, 2018⁷
INFINITY PHARMACEUTICALS, INC.Board member May 23, 2008 to Jun 14, 2018⁸
Vertex PharmaceuticalsChief financial officer Jan 24, 2006 to Aug 9, 2017⁹
IVERIC bioBoard member Aug 4, 2016 to Aug 4, 2016¹⁰

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Odyssey Therapeutics, Inc. ODTX246,100 shares¹¹$4.5M at $18.27May 7, 2026
Solid Biosciences Inc. SLDB138,145 shares¹²$824.7K at $5.97Jul 2, 2026
Foghorn Therapeutics Inc. FHTX72,072 shares¹³$135.1K at $1.88Sep 13, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 2, 2026Exercised options 3,440 shares of Solid Biosciences Inc.¹²
Apr 2, 2026Exercised options 3,441 shares of Solid Biosciences Inc.¹⁴
Jan 6, 2026Exercised options 4,573 shares of Solid Biosciences Inc.¹⁵
Oct 6, 2025Exercised options 4,573 shares of Solid Biosciences Inc.¹⁶
Jul 6, 2025Exercised options 4,573 shares of Solid Biosciences Inc.¹⁷
Apr 6, 2025Exercised options 4,574 shares of Solid Biosciences Inc.¹⁸
Jan 3, 2025Exercised options 3,255 shares of Solid Biosciences Inc.¹⁹
Oct 3, 2024Exercised options 3,255 shares of Solid Biosciences Inc.²⁰
Jul 3, 2024Exercised options 3,255 shares of Solid Biosciences Inc.²¹
Apr 3, 2024Exercised options 3,256 shares of Solid Biosciences Inc.²²
Jan 3, 2024Exercised options 15,570 shares of Solid Biosciences Inc.²³
Oct 3, 2023Exercised options 15,569 shares of Solid Biosciences Inc.²⁴
Jul 3, 2023Exercised options 15,570 shares of Solid Biosciences Inc.²⁵
Apr 3, 2023Exercised options 15,569 shares of Solid Biosciences Inc.²⁶
Jan 3, 2023Exercised options 1,620 shares of Solid Biosciences Inc.²⁷
Dec 2, 2022Granted 13,172 shares of Solid Biosciences Inc.²⁸
Oct 3, 2022Exercised options 24,312 shares of Solid Biosciences Inc.²⁹
Jul 3, 2022Exercised options 24,313 shares of Solid Biosciences Inc.³⁰
Apr 3, 2022Exercised options 24,313 shares of Solid Biosciences Inc.³¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROdyssey Therapeutics, Inc., Board member
2
SEC EDGARStoke Therapeutics, Inc., Chief executive officer
3
SEC EDGARStoke Therapeutics, Inc., Board member
4
SEC EDGARFoghorn Therapeutics Inc., Board member
5
SEC EDGARSolid Biosciences Inc., Board member
6
SEC EDGARVertex Pharmaceuticals, Chief operating officer
7
SEC EDGARAcorda Therapeutics, Board member
8
SEC EDGARINFINITY PHARMACEUTICALS, INC., Board member
9
SEC EDGARVertex Pharmaceuticals, Chief financial officer
10
SEC EDGARIVERIC bio, Board member
11
SEC EDGAROdyssey Therapeutics, Inc. shares after the filing of May 7, 2026
12
SEC EDGARSolid Biosciences Inc. shares after the filing of Jul 2, 2026
13
SEC EDGARFoghorn Therapeutics Inc. shares after the filing of Sep 13, 2022
14
SEC EDGARForm 4 filed Apr 2, 2026
15
SEC EDGARForm 4 filed Jan 7, 2026
16
SEC EDGARForm 4 filed Oct 7, 2025
17
SEC EDGARForm 4 filed Jul 8, 2025
18
SEC EDGARForm 4 filed Apr 8, 2025
19
SEC EDGARForm 4 filed Jan 7, 2025
20
SEC EDGARForm 4 filed Oct 4, 2024
21
SEC EDGARForm 4 filed Jul 5, 2024
22
SEC EDGARForm 4 filed Apr 5, 2024
23
SEC EDGARForm 4 filed Jan 5, 2024
24
SEC EDGARForm 4 filed Oct 5, 2023
25
SEC EDGARForm 4 filed Jul 6, 2023
26
SEC EDGARForm 4 filed Jun 8, 2023
27
SEC EDGARForm 4 filed Jan 5, 2023
28
SEC EDGARForm 4 filed Dec 5, 2022
29
SEC EDGARForm 4 filed Oct 4, 2022
30
SEC EDGARForm 4 filed Jul 6, 2022
31
SEC EDGARForm 4 filed Apr 5, 2022